News & Updates

A study conducted in Germany demonstrates the feasibility of singing-based respiratory training (SBRT) among individuals with post-COVID syndrome (PCS) with respiratory disorders.

Initiating antiretroviral therapy (ART) with the fixed-dose combination of bictegravir, emtricitabine, and tenofovir alafenamide on the same day of HIV diagnosis appears to promote a high level of engagement in care in Taiwan.

The use of inhaled ciclesonide provides no additional benefit to vaccinated adults exposed to Omicron variants of SARS-CoV-2 in fast-tracking their recovery from acute symptoms, a study has shown.

Getting a COVID-19 shot prior to or during pregnancy reduces the risks of severe maternal disease outcomes and preterm birth, and this protection remains consistent across different variant periods, according to a study from Canada.

A systematic review and meta-analysis conducted by researchers in Singapore support ceftazidime-avibactam (CAZ/AVI) as a primary therapeutic alternative for the treatment of OXA-48–producing carbapenem-resistant Enterobacterales (CRE).

In the treatment of uncomplicated urogenital gonorrhoea, a single dose of the novel oral antibiotic zoliflodacin shows similar efficacy and safety profile as the ceftriaxone plus azithromycin combination, as shown in a multinational phase III study.

Children who underwent appendectomy are at increased risk of subsequent nontyphoidal salmonella infection, as shown in a study.

New drug applications approved by US FDA as of 1-15 January 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Select children with persistent vesicoureteral reflux (VUR), especially those without voiding dysfunction, may choose to suspend continuous antibiotic prophylaxis (CAP), suggests a study, noting that a predictive monogram can aid in individualized decision-making.